HOOKIPA Pharma Inc(NASDAQ:HOOK) 
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II cli...
Website: http://www.hookipapharma.com
Founded: 2011
Full Time Employees: 85
CEO: Jörn Aldag
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.86
H 0.90
L 0.82
C 0.82
V 32,139
10EMA 0.82
20EMA 0.82
60EMA 0.82
120EMA 0.82
250EMA 0.82